These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32286800)

  • 41. Antifungal coatings by caspofungin immobilization onto biomaterials surfaces via a plasma polymer interlayer.
    Griesser SS; Jasieniak M; Coad BR; Griesser HJ
    Biointerphases; 2015 Dec; 10(4):04A307. PubMed ID: 26467660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of Poly(Methyl Methacrylate)-Based Polyrotaxane via Reversible Addition-Fragmentation Chain Transfer Polymerization.
    Wang YC; Maeda R; Kali G; Yokoyama H; Wenz G; Ito K
    ACS Macro Lett; 2020 Dec; 9(12):1853-1857. PubMed ID: 35653687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of poly(poly(ethylene glycol) methacrylate)-polyisobutylene ABA block copolymers by the combination of quasiliving carbocationic and atom transfer radical polymerizations.
    Szabó Á; Szarka G; Iván B
    Macromol Rapid Commun; 2015 Jan; 36(2):238-48. PubMed ID: 25353143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.
    Tobudic S; Lassnigg A; Kratzer C; Graninger W; Presterl E
    Mycoses; 2010 May; 53(3):208-14. PubMed ID: 19298353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postantifungal effect of caspofungin against the Candida albicans and Candida parapsilosis clades.
    Gil-Alonso S; Jauregizar N; Eraso E; Quindós G
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):172-7. PubMed ID: 27492134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hydrophilic surface modification of poly(methyl methacrylate)-based ocular prostheses using poly(ethylene glycol) grafting.
    Ko J; Cho K; Han SW; Sung HK; Baek SW; Koh WG; Yoon JS
    Colloids Surf B Biointerfaces; 2017 Oct; 158():287-294. PubMed ID: 28711015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
    O'Shaughnessy EM; Meletiadis J; Stergiopoulou T; Demchok JP; Walsh TJ
    J Antimicrob Chemother; 2006 Dec; 58(6):1168-76. PubMed ID: 17071635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Caspofungin: an echinocandin antifungal agent.
    Stone EA; Fung HB; Kirschenbaum HL
    Clin Ther; 2002 Mar; 24(3):351-77; discussion 329. PubMed ID: 11952021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
    Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
    J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods.
    Roling EE; Klepser ME; Wasson A; Lewis RE; Ernst EJ; Pfaller MA
    Diagn Microbiol Infect Dis; 2002 May; 43(1):13-7. PubMed ID: 12052624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
    Agarwal MB; Rathi SA; Ratho N; Subramanian R
    J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exposure of Aspergillus fumigatus to caspofungin results in the release, and de novo biosynthesis, of gliotoxin.
    Eshwika A; Kelly J; Fallon JP; Kavanagh K
    Med Mycol; 2013 Feb; 51(2):121-7. PubMed ID: 23323804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Total synthesis and structure-activity relationships of new echinocandin-like antifungal cyclolipohexapeptides.
    Yao J; Liu H; Zhou T; Chen H; Miao Z; Sheng C; Zhang W
    Eur J Med Chem; 2012 Apr; 50():196-208. PubMed ID: 22348827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biodegradation of poly(2-hydroxyethyl methacrylate) (PHEMA) and poly{(2-hydroxyethyl methacrylate)-co-[poly(ethylene glycol) methyl ether methacrylate]} hydrogels containing peptide-based cross-linking agents.
    Casadio YS; Brown DH; Chirila TV; Kraatz HB; Baker MV
    Biomacromolecules; 2010 Nov; 11(11):2949-59. PubMed ID: 20961104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Caspofungin: the first representative of a new antifungal class.
    Letscher-Bru V; Herbrecht R
    J Antimicrob Chemother; 2003 Mar; 51(3):513-21. PubMed ID: 12615851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
    Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitigated reactive oxygen species generation leads to an improvement of cell proliferation on poly[glycidyl methacrylate-co-poly(ethylene glycol) methacrylate] functionalized polydimethylsiloxane surfaces.
    Yu L; Shi Z; Gao L; Li C
    J Biomed Mater Res A; 2015 Sep; 103(9):2987-97. PubMed ID: 25711883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro.
    Natesan SK; Chandrasekar PH; Alangaden GJ; Manavathu EK
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):369-73. PubMed ID: 18061388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.